Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions.

Hennekens CH, Dalen JE.

Am J Med. 2013 May;126(5):373-8. doi: 10.1016/j.amjmed.2012.12.013. Epub 2013 Mar 14. Review.

PMID:
23499330
2.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am J Manag Care. 2002 Dec;8(22 Suppl):S691-700. Review.

3.

The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.

Hennekens CH, Schneider WR.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):95-107. Review.

PMID:
18095910
4.
5.

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A.

Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1.

6.

The role of aspirin in cardiovascular diseases--forgotten benefits?

Williams A, Hennekens CH.

Expert Opin Pharmacother. 2004 Jan;5(1):109-15. Review.

PMID:
14680440
7.

An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease.

Hebert PR, Hennekens CH.

Arch Intern Med. 2000 Nov 13;160(20):3123-7.

PMID:
11074741
8.
9.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

10.

Aspirin in the primary prevention of cardiovascular disease: current knowledge and future research needs.

Hennekens CH, Dalen JE.

Trends Cardiovasc Med. 2014 Nov;24(8):360-6. doi: 10.1016/j.tcm.2014.08.006. Epub 2014 Sep 1. Review.

PMID:
25444455
11.

Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients--a longitudinal observational study.

Leung WY, So WY, Stewart D, Lui A, Tong PC, Ko GT, Kong AP, Ma RC, Chan FK, Yang X, Chiang SC, Chan JC.

Cardiovasc Diabetol. 2009 Oct 30;8:57. doi: 10.1186/1475-2840-8-57.

12.

Aspirin usage pre-race to prevent cardiac arrest in marathon runners during races.

Siegel AJ.

Am J Med. 2013 Dec;126(12):e47. doi: 10.1016/j.amjmed.2013.06.024. No abstract available.

PMID:
24262748
13.

Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions.

Hennekens CH, Sechenova O, Hollar D, Serebruany VL.

J Cardiovasc Pharmacol Ther. 2006 Sep;11(3):170-6. Review.

PMID:
17056829
14.

Update on aspirin in the treatment and prevention of cardiovascular disease.

Hennekens CH.

Am Heart J. 1999 Apr;137(4 Pt 2):S9-S13. Review.

PMID:
10097241
15.

[Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].

Volpe M, Abrignani MG, Borghi C, Coccheri S, Gresele P, Patti G, Trimarco B, De Caterina R.

G Ital Cardiol (Rome). 2014 Jul-Aug;15(7-8):442-51. doi: 10.1714/1596.17424. Review. Italian.

PMID:
25174598
16.

Prevention of cardiovascular disease: risks and benefits of aspirin.

Buring JE, Hennekens CH.

J Gen Intern Med. 1990 Sep-Oct;5(5 Suppl):S54-7. Review.

PMID:
2231066
17.

Low-dose aspirin for primary prevention of cardiovascular disease.

Bredie SJ, Wollersheim H, Verheugt FW, Thien T.

Semin Vasc Med. 2003 May;3(2):177-84.

PMID:
15199480
18.

Aspirin in the treatment and prevention of cardiovascular disease.

Gaziano JM, Skerrett PJ, Buring JE.

Haemostasis. 2000;30 Suppl 3:1-13. Review.

PMID:
11182624
19.

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses.

Hennekens CH, Sacks FM, Tonkin A, Jukema JW, Byington RP, Pitt B, Berry DA, Berry SM, Ford NF, Walker AJ, Natarajan K, Sheng-Lin C, Fiedorek FT, Belder R.

Arch Intern Med. 2004 Jan 12;164(1):40-4.

PMID:
14718320
20.

Antiplatelets in stroke prevention.

Pinto A, Di Raimondo D, Tuttolomondo A, Buttà C, Licata G.

Curr Vasc Pharmacol. 2013 Nov;11(6):803-11. Review.

PMID:
24484461
Items per page

Supplemental Content

Write to the Help Desk